Overview
Comprehensive cancer care, research, prevention, and education.
Deals ยท 12mo
1
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Link Cell Therapies | Sep 2026Participated | $30 MSeries A | |
Link Cell Therapies | Sep 2026Participated | $30 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '26 | 1 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 0 |
| $25M-$50M | 1 |
| $50M-$100M | 0 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Bristol Myers Squibb | 1 |
| Johnson & Johnson Innovation | 1 |
| Kyowa Kirin | 1 |
| Samsara BioCapital | 1 |
| Sheatree Capital | 1 |
| Sherpa Healthcare Partners | 1 |
| Western Technology Investment | 1 |
| Wing Venture Capital | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 0 | 0% |
| Participating | 1 | 100% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 0 | 0% |
Lead dynamics requires at least one led deal in this range
Team
Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine
Deputy Director of the Dept of Investigational Therapeutics
Professor
VP, Research
Associate Professor
Department Administrator/Chief Business Officer
Professor
Professor & Director of Computational Pathology